Sampson VB - Search Results

1

MicroRNAs and Potential Targets in Osteosarcoma: Review.

Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. Sampson VB, et al. Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015. Front Pediatr. 2015. PMID: 26380245 Free PMC article. Review.

2

Oncolytic viruses for potential osteosarcoma therapy.

Hingorani P, Sampson V, Lettieri C, Kolb EA. Hingorani P, et al. Adv Exp Med Biol. 2014;804:259-83. doi: 10.1007/978-3-319-04843-7_14. Adv Exp Med Biol. 2014. PMID: 24924179 Review.

3

The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Vetter NS, Kolb EA, Mills CC, Sampson VB. Vetter NS, et al. Among authors: sampson vb. Mol Cancer Res. 2017 Jul;15(7):953-964. doi: 10.1158/1541-7786.MCR-16-0372. Epub 2017 Mar 8. Mol Cancer Res. 2017. PMID: 28275089 Free PMC article.

4

Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer.

Mills CC, Kolb EA, Sampson VB. Mills CC, et al. Among authors: sampson vb. Cancer Res. 2017 Dec 1;77(23):6489-6498. doi: 10.1158/0008-5472.CAN-17-2066. Epub 2017 Nov 2. Cancer Res. 2017. PMID: 29097609 Free PMC article. Review.

5

Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.

Mills CC, Kolb EA, Sampson VB. Mills CC, et al. Among authors: sampson vb. Cancer Res. 2018 Jan 15;78(2):320-325. doi: 10.1158/0008-5472.CAN-17-2782. Epub 2018 Jan 8. Cancer Res. 2018. PMID: 29311160 Free PMC article. Review.

6

p27/Kip1 functions as a tumor suppressor and oncoprotein in osteosarcoma.

Currier AW, Kolb EA, Gorlick RG, Roth ME, Gopalakrishnan V, Sampson VB. Currier AW, et al. Among authors: sampson vb. Sci Rep. 2019 Apr 16;9(1):6161. doi: 10.1038/s41598-019-42450-0. Sci Rep. 2019. PMID: 30992462 Free PMC article.

7

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.

Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA. Sampson VB, et al. Oncotarget. 2016 Dec 27;7(52):86594-86607. doi: 10.18632/oncotarget.13358. Oncotarget. 2016. PMID: 27863409 Free PMC article.

8

Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.

Sampson VB, Kamara DF, Kolb EA. Sampson VB, et al. Expert Opin Drug Discov. 2013 Oct;8(10):1181-9. doi: 10.1517/17460441.2013.817988. Epub 2013 Jul 12. Expert Opin Drug Discov. 2013. PMID: 23844615 Free PMC article. Review.

9

Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.

Sampson VB, Vetter NS, Kamara DF, Collier AB, Gresh RC, Kolb EA. Sampson VB, et al. PLoS One. 2015 Nov 16;10(11):e0142704. doi: 10.1371/journal.pone.0142704. eCollection 2015. PLoS One. 2015. PMID: 26571493 Free PMC article.

10

A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.

Kolb EA, Sampson V, Stabley D, Walter A, Sol-Church K, Cripe T, Hingorani P, Ahern CH, Weigel BJ, Zwiebel J, Blaney SM. Kolb EA, et al. Pediatr Blood Cancer. 2015 May;62(5):751-8. doi: 10.1002/pbc.25464. Epub 2015 Feb 27. Pediatr Blood Cancer. 2015. PMID: 25728527 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page